Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y8RM
|
|||
Former ID |
DNC003238
|
|||
Drug Name |
(1r)-1,2,2-trimethylpropyl (r)-methylphosphinate
|
|||
Synonyms |
GD7
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
![]() |
Download2D MOL
|
||
Formula |
C7H16O2P+
|
|||
Canonical SMILES |
CC(C(C)(C)C)O[P+](=O)C
|
|||
InChI |
1S/C7H16O2P/c1-6(7(2,3)4)9-10(5)8/h6H,1-5H3/q+1/t6-/m1/s1
|
|||
InChIKey |
AYQIEWWYFGQKPK-ZCFIWIBFSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Liver carboxylesterase (CES1) | Target Info | Inhibitor | [1] |
Platelet-activating factor acetylhydrolase (PLA2G7) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Ether lipid metabolism | |||
Metabolic pathways | ||||
Biosynthesis of antibiotics | ||||
Drug metabolism - other enzymes | ||||
Pathway Interaction Database | Lissencephaly gene (LIS1) in neuronal migration and development | |||
E2F transcription factor network | ||||
WikiPathways | IL1 and megakaryotyces in obesity | |||
Synthesis, Secretion, and Deacylation of Ghrelin | ||||
NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | ||||
Heroin metabolism | ||||
Irinotecan Pathway | ||||
Fluoropyrimidine Activity | ||||
Phase I biotransformations, non P450 |
References | Top | |||
---|---|---|---|---|
REF 1 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.